Back to Search
Start Over
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1α-XBP1 pathway.
- Source :
- Journal of Zhejiang University: Science B; May2022, Vol. 23 Issue 5, p392-406, 15p
- Publication Year :
- 2022
-
Abstract
- <i>Copyright of Journal of Zhejiang University: Science B is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
Details
- Language :
- English
- ISSN :
- 16731581
- Volume :
- 23
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Journal of Zhejiang University: Science B
- Publication Type :
- Academic Journal
- Accession number :
- 157005214
- Full Text :
- https://doi.org/10.1631/jzus.B2100780